Google.org

Google.org is a philanthropic arm of Google, a multinational technology company. It funds and supports nonprofits globally, providing them with funding, tools, and volunteers. Google.org has committed approximately $100 million annually to these efforts, aiming to extend the reach of innovative nonprofits and create lasting global impact.

Ekta Aggarwal

Principal Account Manager

John Bell

CEO-Founder

Sumiran Das

Growth Equity Investor at Google Capital

Jacquelline Fuller

President

Raj Gajwani

Director, Orion Wifi @ Google Area 120

Carletta Higginson

Director, Global Head of Music Publishing

Rahul Jain

Lead, Venture Capital and Startups - Google Cloud

Aftab Jutt

CEO

Sushrut Karanjkar

Director

Jess Kuizon

CEO

Bibiana Leite

Director, Scaled Partnerships

Anthony Nakache

Managing Director, Google MENA

David Reshef

Venture Partner

Issi Rozen

Venture Partner

Philipp Schindler

Senior Vice President and Chief Business Officer

Andrew R. Whalley

Director, Chrome Security

Andy Wheeler

General Partner

LightRoom Premium Mod APK Download Android

CEO

Co khi Nhan Do

CEO

Past deals in Predictive Analytics

Layer Health

Series A in 2025
Layer Health is a technology company specializing in AI-driven healthcare information solutions. It develops an AI-powered platform designed to help healthcare providers extract valuable insights from patient data, enabling them to make informed decisions, enhance patient care, and improve operational efficiency. The platform focuses on processing unstructured data from clinical, administrative, and research sources, transforming it into actionable insights.

Clear Labs

Series D in 2025
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive food analytics platform that utilizes next-generation sequencing and data analytics to enhance food safety and quality control. Its offerings include Clear Dx™ and Clear Safety™, which facilitate the rapid identification of pathogens and support public health initiatives. Clear Labs' platform delivers critical insights into the molecular composition of foods and ingredients, testing for authenticity, contaminants, allergens, and other safety parameters. By offering transparency across supply chains, the company serves food manufacturers, suppliers, and retailers, enabling them to improve operational efficiency and safety through detailed analytics and reporting.

PGxAI

Grant in 2024
PGxAI is an AI-powered pharmacogenetics platform that redefines precision medicine using proprietary algorithms and real-world data. Partnered with InterSystems, the largest patient data holder globally, and leveraging advanced tools like VectorSearch and GenAI, PGxAI accesses extensive real-world data to solve drug selection, dosage personalization, and identification of clinically relevant drug-drug interactions.

Climate X

Series A in 2024
Climate X is a global climate physical risk data analytics company that specializes in climate risk management services. The firm provides tools to project and predict the impacts of climate change and extreme weather events by integrating climate models with current real-world data. Through its physical modeling capabilities, Climate X enables businesses and governments to anticipate regulatory requirements and adapt to evolving climate-related challenges. Its clientele includes prominent financial institutions in sectors such as banking, real estate, and insurance, highlighting its relevance in a rapidly changing climate landscape.

Alethea

Series B in 2024
Alethea is a technology company helping the Fortune 500, private companies and nonprofits protect themselves from harms stemming from disinformation. Leveraging its multi-channel machine learning platform, Artemis, Alethea detects disinformation narratives across the internet, enabling customers to proactively defend against this pervasive threat. With Artemis-powered early detection, Alethea customers can protect their reputations, key assets, physical safety and market value. The company was founded in 2019 and is woman owned.

W4A.io

Grant in 2024
Precursor to intelligent Hominid aka Silico Sapiens; Working on technologies of Web 4.0 or the fourth generation of web. Web 4.0 is symbiotic web, where Human and machines work in symbiosis. The idea being the symbiotic web is that once the metadata is organized humans and machines can interact in symbiosis with each other. Join the Web 4.0 community on w4a.io that is home to hundreds of thousands of developers, technologists, designers, users and enthusiasts.

Moonwalk Biosciences

Series A in 2024
Moonwalk Biosciences is a genomic medicine startup focused on developing precision epigenetic therapeutics. The company specializes in creating a profiling and engineering technology platform that leverages advanced artificial intelligence predictions to offer a comprehensive view of the epigenome in both health and disease states. This innovative approach aims to revolutionize therapy discovery and development, enabling healthcare providers to reprogram cells back to their healthy state.

Wright Research

Non Equity Assistance in 2023
Wright Research is a quantitative active investment firm that specializes in data-driven robo-investment management and advisory services. It caters to investors with varying risk profiles by employing purely quantitative investment management strategies. The firm utilizes extensive historical data, which includes fundamental, technical, macroeconomic, and alternative data, along with rigorous statistical testing to eliminate investor biases and backtesting errors. This approach provides clients with comprehensive analysis and tracking tools, enabling both individuals and businesses to engage in quantitative investing and enhance their returns. Wright Research is committed to helping investors achieve their financial objectives while effectively navigating investment risks.

Endimension Technology

Non Equity Assistance in 2023
Endimension Technology specializes in artificial intelligence solutions for medical image analysis. The company focuses on developing platforms that automatically identify abnormalities and diseases in medical scans, thus enhancing the accuracy of diagnoses and reducing the risk of misdiagnosis. By employing advanced AI algorithms and predictive analytics, Endimension aims to improve early-stage disease detection, ultimately streamlining workflows within healthcare organizations and increasing the efficiency of radiologists. The company's innovations contribute to better patient outcomes by facilitating timely and accurate medical assessments.

Layer Health

Seed Round in 2023
Layer Health is a technology company specializing in AI-driven healthcare information solutions. It develops an AI-powered platform designed to help healthcare providers extract valuable insights from patient data, enabling them to make informed decisions, enhance patient care, and improve operational efficiency. The platform focuses on processing unstructured data from clinical, administrative, and research sources, transforming it into actionable insights.

Signos

Series B in 2023
Signos is a health technology company focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through innovative solutions. The company offers a weight loss application that leverages continuous glucose monitoring in conjunction with an AI-enhanced platform. This combination provides users with real-time data and personalized recommendations for meals and exercises tailored to their unique metabolic responses. By enabling individuals to better understand their body's reactions to food, Signos aims to facilitate effective weight loss and foster sustainable health improvements. With a significant portion of the American population facing weight-related challenges, Signos presents a modern approach to support users on their journey towards healthier living.

Aifficient.Tech

Pre Seed Round in 2023
AIfficient.Tech is a revolutionary platform designed to empower small and medium-sized enterprises (SMEs) through the power of artificial intelligence. With a focus on enhancing productivity, efficiency, and innovation, AIfficient.Tech offers a wide range of AI-driven services tailored to meet the unique needs of businesses across various industries. Our mission is to level the playing field for SMEs by providing them with AI solutions that were previously accessible only to industry giants. We aim to help businesses work smarter, not harder, by automating routine tasks and providing real-time data and predictive analytics for informed decision-making. What sets AIfficient.Tech apart is our extensive library of 1,500 predefined and trained Autonomous AI Agents, classified using ONET codes, that cater to a wide array of functions and industries. These roles act as intelligent virtual employees, known as Cognitive Autonomous Agents, that integrate seamlessly into existing workflows.

Causal Foundry

Grant in 2023
Causal Foundry is a personalization to solve the greatest challenges in healthcare and medicine.

Graft

Venture Round in 2023
Graft is a modern artificial intelligence platform that empowers data teams to develop production-ready AI solutions with minimal effort and without requiring specialized machine learning skills. The company offers a cloud-native platform designed for the analysis of unstructured data, including text, images, video, audio, and graphs. By leveraging advanced AI technologies, Graft enables clients to effectively analyze and utilize unstructured data, facilitating improved decision-making and business outcomes. This data-centric approach allows organizations to harness the power of foundation models, thereby streamlining the process of building and deploying AI applications without the need for extensive infrastructure or dedicated teams.

Paradigm

Series A in 2023
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.

CropIn

Series D in 2022
CropIn, founded in 2010, is a pioneer in the Agtech sector, offering an innovative platform known as the Intelligent Agriculture Cloud. This platform empowers stakeholders in the agricultural ecosystem to utilize digitization and artificial intelligence to enhance decision-making, increase efficiency, and promote sustainability. CropIn has partnered with over 250 customers and digitized 16 million acres of farmland, positively impacting the livelihoods of more than 7 million farmers. The company has amassed extensive farming data insights, covering 488 crops and 10,000 crop varieties across 56 countries, making it a leader in the global 'Ag-intelligence' movement. Its AI and machine learning solutions are specifically designed for the agricultural industry, enabling comprehensive monitoring and management of farm operations. By integrating information and communication technology with traditional farming practices, CropIn aims to improve both the financial and operational aspects of agriculture, ensuring quality and safety in food production.

Upollo

Pre Seed Round in 2022
Upollo is a company that specializes in accelerating the growth of subscription-based businesses by predicting customer behavior, including churn and expansion opportunities. The platform analyzes extensive data, including over half a billion dollars in subscription revenue and billions of user interactions, to offer actionable insights to customer success teams, sales, and marketing departments. By identifying potential churn before it occurs and revealing opportunities for revenue expansion, Upollo enables businesses to enhance customer engagement and optimize conversion rates. Additionally, the platform provides real-time insights into user behavior, such as account sharing and the use of disposable contact information, allowing companies to foster positive interactions with potential customers who may be undecided about subscribing.

BreezoMeter

Acquisition in 2022
BreezoMeter Ltd., established in 2014, operates a real-time air-quality analytics platform that provides street-level data on air pollution, pollen, and active fires. Headquartered in Haifa, Israel, with an additional office in the United States, BreezoMeter serves consumers and businesses globally by offering personalized health solutions based on accurate, location-specific air quality information. Its proprietary algorithms integrate data from various sources such as governmental sensors, satellites, weather patterns, and traffic to deliver precise air quality insights up to a resolution of 5 meters hourly in over 90 countries. BreezoMeter's clients include prominent product and healthcare brands like Siemens and ALK, attracted by its unmatched real-time accuracy and published validation process.

Verily

Corporate Round in 2022
Verily is an Alphabet health technology company focused on research, care, and health financing to deliver on the promise of precision health and help people live healthier lives. We are uniquely positioned at the intersection of technology, data science, and healthcare to create tools to accelerate evidence generation, products to enable more personalized care, and approaches to make costs more predictable. For more information about Verily please visit verily.com. The company was founded in 2015 and is based in San Francisco, California, United States.

Mirvie

Series B in 2022
Mirvie is a biotechnology company specializing in non-invasive tests for maternal-fetal health, aimed at enhancing the safety of pregnancy. Founded in 2018 by Maneesh Jain and based in South San Francisco, California, Mirvie provides predictive diagnostic tools that deliver actionable insights to expectant mothers and families. Its medical diagnostic platform enables healthcare practitioners to identify at-risk pregnancies, facilitating timely interventions and therapeutic approaches to improve pregnancy outcomes. Through its innovative solutions, Mirvie seeks to empower families with critical information, ensuring a safer pregnancy experience.

Graft

Pre Seed Round in 2022
Graft is a modern artificial intelligence platform that empowers data teams to develop production-ready AI solutions with minimal effort and without requiring specialized machine learning skills. The company offers a cloud-native platform designed for the analysis of unstructured data, including text, images, video, audio, and graphs. By leveraging advanced AI technologies, Graft enables clients to effectively analyze and utilize unstructured data, facilitating improved decision-making and business outcomes. This data-centric approach allows organizations to harness the power of foundation models, thereby streamlining the process of building and deploying AI applications without the need for extensive infrastructure or dedicated teams.

Waltz Health

Series A in 2022
Waltz Health is a company focused on innovating the pharmaceutical supply chain by developing technology-driven solutions for pricing, distribution, and prescription of medications. It collaborates with various partners, including consumers, payers, and pharmacies, to create smarter ways to manage prescription care. The company utilizes AI-driven marketplaces to reduce costs and offers consumer tools that enhance decision-making regarding healthcare. These tools provide users with better pricing, comprehensive information, and resources aimed at lowering expenses, empowering consumers, and enabling payers to effectively manage their pharmacy benefits. Through these efforts, Waltz Health strives to improve the overall experience and affordability of prescription medications.

Pecan

Series C in 2022
Pecan is a developer of a low-code predictive analytics platform that empowers businesses to make informed decisions by predicting future outcomes. The platform is designed for business intelligence, operations, and revenue teams, enabling them to leverage artificial intelligence and predictive modeling without the necessity of in-house data scientists or engineers. Pecan simplifies data preparation, automates feature engineering, and provides pre-built models tailored for specific use cases, allowing SQL-trained analysts to generate accurate predictions quickly. By transforming raw data into actionable insights, Pecan assists companies in enhancing customer lifetime value, improving retention and conversion rates, and refining demand forecasting, thereby positively impacting revenue across various sectors, including fintech, insurance, retail, and consumer services.

InstaDeep

Series B in 2022
InstaDeep Ltd is a company that specializes in developing artificial intelligence-based decision-making systems for the enterprise sector. Founded in 2014 and headquartered in London, the company has additional offices in Paris, Tunis, Nairobi, and Lagos. InstaDeep offers a platform that enhances decision-making through various AI technologies, including optimized pattern recognition, GPU-accelerated insights, self-learning systems, machine learning, and predictive analytics. These tools are designed to help businesses improve operational efficiency across multiple domains such as manufacturing, logistics, mobility, and energy. By leveraging these capabilities, InstaDeep aims to increase return on investment for its clients while also focusing on talent retention and training.

Signos

Series A in 2021
Signos is a health technology company focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through innovative solutions. The company offers a weight loss application that leverages continuous glucose monitoring in conjunction with an AI-enhanced platform. This combination provides users with real-time data and personalized recommendations for meals and exercises tailored to their unique metabolic responses. By enabling individuals to better understand their body's reactions to food, Signos aims to facilitate effective weight loss and foster sustainable health improvements. With a significant portion of the American population facing weight-related challenges, Signos presents a modern approach to support users on their journey towards healthier living.

Yellowbrick Data

Series C in 2021
Yellowbrick Data, Inc. is a data warehousing company founded in 2014 and headquartered in Palo Alto, California, with additional offices in Salt Lake City, Hong Kong, and London. The company specializes in developing and deploying a data warehouse platform that enables organizations to store, transform, and analyze large volumes of business data efficiently and securely. Yellowbrick's solutions include on-premises and cloud-based data warehouse appliances, as well as cloud disaster recovery options. The platform is designed to support thousands of concurrent users and can handle petabytes of data, offering superior performance and cost-effectiveness. It facilitates the execution of complex mixed workloads and ad-hoc SQL queries while providing companies with the ability to run analytics in hybrid cloud environments. By simplifying data warehousing challenges, Yellowbrick Data empowers enterprises to make faster, data-driven decisions.

Snorkel AI

Series C in 2021
Snorkel AI, Inc. is a technology company that specializes in developing an end-to-end machine-learning platform designed to facilitate the creation, management, and monitoring of AI applications. Founded in 2016 and based in Palo Alto, California, the company offers Snorkel Flow, a platform that enables programmatic data labeling, augmentation, and curation. This platform supports the clean integration and management of data for AI, as well as the training and deployment of various models. Snorkel AI's technology is particularly adept at extracting entities, relationships, and structured information from complex documents and forms, while also ranking content based on relevance and other factors. The company serves diverse sectors, including finance, government, telecommunications, insurance, healthcare, and e-commerce, and is recognized for its contributions to AI research through peer-reviewed publications.

Clear Labs

Series C in 2021
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive food analytics platform that utilizes next-generation sequencing and data analytics to enhance food safety and quality control. Its offerings include Clear Dx™ and Clear Safety™, which facilitate the rapid identification of pathogens and support public health initiatives. Clear Labs' platform delivers critical insights into the molecular composition of foods and ingredients, testing for authenticity, contaminants, allergens, and other safety parameters. By offering transparency across supply chains, the company serves food manufacturers, suppliers, and retailers, enabling them to improve operational efficiency and safety through detailed analytics and reporting.

AWB BioTech

Series B in 2021
AWB BioTech uses data from preclinical and clinical studies to guide a drug’s effect on patients.

Saildrone

Grant in 2021
Saildrone, Inc. is a company based in Alameda, California, that specializes in the design and manufacture of autonomous sailing drones powered by wind and solar energy. Founded in 2012, Saildrone operates a fleet of these unmanned surface vehicles to collect and deliver live ocean data for various applications, including weather forecasting, oceanography, climate research, fish stock analysis, and environmental monitoring. The company has successfully sailed over 500,000 nautical miles and spent more than 13,000 days at sea, generating high-resolution datasets that provide critical intelligence for climate, mapping, and maritime security. By leveraging advanced technologies, Saildrone enables cost-effective and scalable ocean data collection, ultimately aiming to enhance understanding of planetary systems and mitigate ecological disasters.

Snorkel AI

Series B in 2021
Snorkel AI, Inc. is a technology company that specializes in developing an end-to-end machine-learning platform designed to facilitate the creation, management, and monitoring of AI applications. Founded in 2016 and based in Palo Alto, California, the company offers Snorkel Flow, a platform that enables programmatic data labeling, augmentation, and curation. This platform supports the clean integration and management of data for AI, as well as the training and deployment of various models. Snorkel AI's technology is particularly adept at extracting entities, relationships, and structured information from complex documents and forms, while also ranking content based on relevance and other factors. The company serves diverse sectors, including finance, government, telecommunications, insurance, healthcare, and e-commerce, and is recognized for its contributions to AI research through peer-reviewed publications.

insitro

Series C in 2021
Insitro, Inc. is a data-driven company focused on drug discovery and development, particularly targeting nonalcoholic steatohepatitis (NASH). Founded in 2018 by Daphne Koller and based in South San Francisco, California, Insitro harnesses machine learning and high-throughput biology to revolutionize the process of drug discovery. The company creates extensive functional genomic data sets and integrates them with patient data through innovative machine learning techniques. This approach allows Insitro to build predictive models that enhance target selection, streamline the design of therapeutics, and optimize drug development strategies. By addressing critical challenges in pharmaceutical research and development, Insitro aims to accelerate the delivery of new and effective treatments to patients.

Olive

Venture Round in 2020
Olive AI, Inc. specializes in developing artificial intelligence and robotic process automation solutions tailored for healthcare organizations. Founded in 2012 and based in Columbus, Ohio, the company offers an AI-as-a-Service platform that automates a variety of administrative workflows, including claim status checks, account updates, and prior authorizations. By streamlining these repetitive and high-volume tasks, Olive allows healthcare professionals to focus on more creative and empathetic aspects of patient care. The software acts as an intermediary between different systems and data, helping to reduce administrative errors and improve cash collections, ultimately enhancing overall efficiency and patient outcomes in the healthcare sector. Olive AI, Inc. was previously known as CrossChx, Inc. before rebranding in July 2018.

Arkangel AI

Grant in 2020
Arkangel AI is a technology company that provides a no-code platform designed for healthcare organizations to harness the capabilities of artificial intelligence. Its platform enables the building, deployment, and management of machine learning algorithms at scale, focusing on the detection of preventable diseases. By generating detection results that are faster, more accurate, and cost-effective, Arkangel AI helps users identify the stage of health issues efficiently. The company's mission is to promote equitable health conditions globally, empowering individuals to live free from preventable diseases. Through its innovative solutions, Arkangel AI aims to enhance healthcare outcomes and accessibility for all.

Snorkel AI

Seed Round in 2020
Snorkel AI, Inc. is a technology company that specializes in developing an end-to-end machine-learning platform designed to facilitate the creation, management, and monitoring of AI applications. Founded in 2016 and based in Palo Alto, California, the company offers Snorkel Flow, a platform that enables programmatic data labeling, augmentation, and curation. This platform supports the clean integration and management of data for AI, as well as the training and deployment of various models. Snorkel AI's technology is particularly adept at extracting entities, relationships, and structured information from complex documents and forms, while also ranking content based on relevance and other factors. The company serves diverse sectors, including finance, government, telecommunications, insurance, healthcare, and e-commerce, and is recognized for its contributions to AI research through peer-reviewed publications.

Snorkel AI

Series A in 2020
Snorkel AI, Inc. is a technology company that specializes in developing an end-to-end machine-learning platform designed to facilitate the creation, management, and monitoring of AI applications. Founded in 2016 and based in Palo Alto, California, the company offers Snorkel Flow, a platform that enables programmatic data labeling, augmentation, and curation. This platform supports the clean integration and management of data for AI, as well as the training and deployment of various models. Snorkel AI's technology is particularly adept at extracting entities, relationships, and structured information from complex documents and forms, while also ranking content based on relevance and other factors. The company serves diverse sectors, including finance, government, telecommunications, insurance, healthcare, and e-commerce, and is recognized for its contributions to AI research through peer-reviewed publications.

PatientPing

Series C in 2020
PatientPing, Inc. is a health technology company that has developed a national care coordination network aimed at enhancing communication among healthcare providers. Founded in 2013 and headquartered in Boston, Massachusetts, the company offers real-time notifications and care guidelines to various healthcare professionals, including physicians, nurses, case managers, and care coordinators. This network spans hospitals, emergency departments, accountable care organizations, physician practices, skilled nursing facilities, home health agencies, and payers. PatientPing's platform includes a tool called Spotlights, which leverages real-time data to analyze utilization and performance trends in patient care. By improving information sharing among care teams, PatientPing facilitates higher quality, cost-effective care, ultimately aiming to enhance patient outcomes and experiences. The company also maintains a strategic partnership with MedAllies, Inc. and operates as a subsidiary of SVB Leerink Holdings LLC.

insitro

Series B in 2020
Insitro, Inc. is a data-driven company focused on drug discovery and development, particularly targeting nonalcoholic steatohepatitis (NASH). Founded in 2018 by Daphne Koller and based in South San Francisco, California, Insitro harnesses machine learning and high-throughput biology to revolutionize the process of drug discovery. The company creates extensive functional genomic data sets and integrates them with patient data through innovative machine learning techniques. This approach allows Insitro to build predictive models that enhance target selection, streamline the design of therapeutics, and optimize drug development strategies. By addressing critical challenges in pharmaceutical research and development, Insitro aims to accelerate the delivery of new and effective treatments to patients.

Clear Labs

Venture Round in 2020
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive food analytics platform that utilizes next-generation sequencing and data analytics to enhance food safety and quality control. Its offerings include Clear Dx™ and Clear Safety™, which facilitate the rapid identification of pathogens and support public health initiatives. Clear Labs' platform delivers critical insights into the molecular composition of foods and ingredients, testing for authenticity, contaminants, allergens, and other safety parameters. By offering transparency across supply chains, the company serves food manufacturers, suppliers, and retailers, enabling them to improve operational efficiency and safety through detailed analytics and reporting.

Owkin

Series A in 2020
Owkin, Inc. is an artificial intelligence company that specializes in developing software aimed at improving treatment outcomes for patients, particularly in oncology. Established in 2016, with headquarters in New York and an office in Paris, Owkin employs AI tools to enhance drug discovery and accelerate clinical trials while safeguarding patient privacy through federated learning. The company offers several products, including Owkin Lab for therapeutic data connection, Owkin Loop for validated and packaged models, and a comprehensive software stack. Owkin's portfolio includes 30 live models, with an additional 40 in development, focusing on identifying new drug candidates and elucidating the mechanisms behind treatment efficacy. Co-founded by Thomas Clozel, a clinical research doctor, and Gilles Wainrib, a machine learning expert, Owkin has raised over $255 million and achieved unicorn status due to its innovative approach in addressing unmet medical needs and optimizing the drug development process.

Yellowbrick Data

Series C in 2019
Yellowbrick Data, Inc. is a data warehousing company founded in 2014 and headquartered in Palo Alto, California, with additional offices in Salt Lake City, Hong Kong, and London. The company specializes in developing and deploying a data warehouse platform that enables organizations to store, transform, and analyze large volumes of business data efficiently and securely. Yellowbrick's solutions include on-premises and cloud-based data warehouse appliances, as well as cloud disaster recovery options. The platform is designed to support thousands of concurrent users and can handle petabytes of data, offering superior performance and cost-effectiveness. It facilitates the execution of complex mixed workloads and ad-hoc SQL queries while providing companies with the ability to run analytics in hybrid cloud environments. By simplifying data warehousing challenges, Yellowbrick Data empowers enterprises to make faster, data-driven decisions.

Owkin

Series A in 2019
Owkin, Inc. is an artificial intelligence company that specializes in developing software aimed at improving treatment outcomes for patients, particularly in oncology. Established in 2016, with headquarters in New York and an office in Paris, Owkin employs AI tools to enhance drug discovery and accelerate clinical trials while safeguarding patient privacy through federated learning. The company offers several products, including Owkin Lab for therapeutic data connection, Owkin Loop for validated and packaged models, and a comprehensive software stack. Owkin's portfolio includes 30 live models, with an additional 40 in development, focusing on identifying new drug candidates and elucidating the mechanisms behind treatment efficacy. Co-founded by Thomas Clozel, a clinical research doctor, and Gilles Wainrib, a machine learning expert, Owkin has raised over $255 million and achieved unicorn status due to its innovative approach in addressing unmet medical needs and optimizing the drug development process.

Pindrop

Series D in 2018
Pindrop is a developer of advanced phone fraud detection and call center authentication technology, focused on enhancing security, identity, and trust in voice interactions. The company offers solutions that authenticate phone devices through call audio analysis, enabling the detection of fraudulent calls and the verification of legitimate callers. By leveraging a comprehensive risk database, Pindrop's technology helps enterprise call centers and businesses streamline communication, reduce call handling time, and improve customer experience while minimizing fraud losses. With a commitment to unlocking the value of voice interactions, Pindrop is positioned to support both enterprises and consumers in navigating a voice-driven future.

UjuziKilimo

Grant in 2018
UjuziKilimo is a data-driven agronomy services company that specializes in collecting and analyzing farm data to enhance decision-making for farmers and agricultural stakeholders. By leveraging innovative data acquisition technologies, data science, and machine learning, UjuziKilimo offers actionable agronomic insights that enable farmers to improve crop productivity. The company also provides business intelligence and predictive analytics to agriculture service providers and businesses through a fully integrated data platform, which is powered by extensive datasets. This approach allows UjuziKilimo to facilitate knowledge sharing and optimize farming practices using mobile technology, ultimately supporting the growth and efficiency of the agricultural sector.

Vetsark

Grant in 2018
Vetsark is a company that specializes in enhancing productivity and profitability for agribusinesses by facilitating their digital transformation. It develops practice management software designed to streamline business operations and assign tasks effectively. The platform provides real-time business analytics and predictive insights, allowing veterinarians to assess productivity and make informed decisions. Additionally, Vetsark utilizes disease report data to predict, prevent, and manage outbreaks, benefiting livestock farmers, veterinarians, and public health efforts. Through its innovative solutions, Vetsark aims to empower agribusinesses to optimize their operations and increase their income.

Machinify

Series A in 2018
Machinify, Inc. is a company that operates a data-to-cash platform aimed at optimizing enterprise operations through artificial intelligence. Founded in 2016 and based in Palo Alto, California, Machinify leverages AI technology to help businesses effectively process their data and uncover hidden profits through automated decision-making. Its offerings include AI Cloud, which manages semi-structured and unstructured real-time data; AI Studio, which facilitates the automated building and testing of AI models through a user-friendly interface; and AI Runtime, which generates the necessary infrastructure for real-time or batch predictions. By automating data collection, transformation, and product deployment, Machinify enables domain experts to transform raw data into smart, automated decisions, ultimately reducing the time required to develop and deploy AI-driven solutions across various sectors, including healthcare.

Yellowbrick Data

Series A in 2018
Yellowbrick Data, Inc. is a data warehousing company founded in 2014 and headquartered in Palo Alto, California, with additional offices in Salt Lake City, Hong Kong, and London. The company specializes in developing and deploying a data warehouse platform that enables organizations to store, transform, and analyze large volumes of business data efficiently and securely. Yellowbrick's solutions include on-premises and cloud-based data warehouse appliances, as well as cloud disaster recovery options. The platform is designed to support thousands of concurrent users and can handle petabytes of data, offering superior performance and cost-effectiveness. It facilitates the execution of complex mixed workloads and ad-hoc SQL queries while providing companies with the ability to run analytics in hybrid cloud environments. By simplifying data warehousing challenges, Yellowbrick Data empowers enterprises to make faster, data-driven decisions.

Owkin

Series A in 2018
Owkin, Inc. is an artificial intelligence company that specializes in developing software aimed at improving treatment outcomes for patients, particularly in oncology. Established in 2016, with headquarters in New York and an office in Paris, Owkin employs AI tools to enhance drug discovery and accelerate clinical trials while safeguarding patient privacy through federated learning. The company offers several products, including Owkin Lab for therapeutic data connection, Owkin Loop for validated and packaged models, and a comprehensive software stack. Owkin's portfolio includes 30 live models, with an additional 40 in development, focusing on identifying new drug candidates and elucidating the mechanisms behind treatment efficacy. Co-founded by Thomas Clozel, a clinical research doctor, and Gilles Wainrib, a machine learning expert, Owkin has raised over $255 million and achieved unicorn status due to its innovative approach in addressing unmet medical needs and optimizing the drug development process.

insitro

Series A in 2018
Insitro, Inc. is a data-driven company focused on drug discovery and development, particularly targeting nonalcoholic steatohepatitis (NASH). Founded in 2018 by Daphne Koller and based in South San Francisco, California, Insitro harnesses machine learning and high-throughput biology to revolutionize the process of drug discovery. The company creates extensive functional genomic data sets and integrates them with patient data through innovative machine learning techniques. This approach allows Insitro to build predictive models that enhance target selection, streamline the design of therapeutics, and optimize drug development strategies. By addressing critical challenges in pharmaceutical research and development, Insitro aims to accelerate the delivery of new and effective treatments to patients.

Cohesity

Series C in 2017
Cohesity, Inc. is a data management technology company that specializes in hyper-converged secondary storage solutions for large organizations. Founded in 2013 and based in Santa Clara, California, with an additional office in Raleigh, North Carolina, Cohesity aims to simplify the protection, management, and extraction of value from data. Its flagship product, the Cohesity DataPlatform, consolidates secondary data and workflows, eliminating storage silos and streamlining data management. The company also offers DataProtect, which integrates various data protection functions, including backup and disaster recovery, as well as the Cohesity Orion platform for comprehensive data protection and big data storage. Additionally, Cohesity provides tools for monitoring and managing data infrastructure through its SaaS-based solution, Cohesity Helios, and its mobile application. The company serves clients across the Americas, EMEA, and APAC, and maintains a strategic partnership with Pure Storage to enhance its offerings.

Kaggle

Acquisition in 2017
Kaggle Inc. is a prominent platform for data prediction competitions, catering to a diverse range of industries including pharmaceuticals, financial services, energy, and retail. Founded in 2010 and based in San Francisco, the company allows organizations to post their data for analysis by a global community of data scientists. Through its competitions, Kaggle fosters collaboration and innovation in solving complex data science problems, utilizing advanced machine learning techniques. In addition to hosting competitions, Kaggle offers tools such as Kaggle Prospect, which assists companies and governments in transforming their data sets into actionable insights. As a subsidiary of Google, Kaggle serves both domestic and international clients, delivering cutting-edge business results and addressing real-world challenges across various sectors.

Clear Labs

Series B in 2016
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive food analytics platform that utilizes next-generation sequencing and data analytics to enhance food safety and quality control. Its offerings include Clear Dx™ and Clear Safety™, which facilitate the rapid identification of pathogens and support public health initiatives. Clear Labs' platform delivers critical insights into the molecular composition of foods and ingredients, testing for authenticity, contaminants, allergens, and other safety parameters. By offering transparency across supply chains, the company serves food manufacturers, suppliers, and retailers, enabling them to improve operational efficiency and safety through detailed analytics and reporting.

Pindrop

Series C in 2016
Pindrop is a developer of advanced phone fraud detection and call center authentication technology, focused on enhancing security, identity, and trust in voice interactions. The company offers solutions that authenticate phone devices through call audio analysis, enabling the detection of fraudulent calls and the verification of legitimate callers. By leveraging a comprehensive risk database, Pindrop's technology helps enterprise call centers and businesses streamline communication, reduce call handling time, and improve customer experience while minimizing fraud losses. With a commitment to unlocking the value of voice interactions, Pindrop is positioned to support both enterprises and consumers in navigating a voice-driven future.

ClearStory Data

Venture Round in 2016
ClearStory Data Inc. is a data analytics company based in Menlo Park, California, with an additional office in Chicago, Illinois. Founded in 2011, it provides business-oriented data analytics solutions that cater to a variety of industries, including consumer packaged goods, healthcare, manufacturing, and financial services. ClearStory Data's platform enables organizations to discover, analyze, and utilize data from various sources, such as relational databases, web applications, and third-party providers. The solution is designed to simplify access to disparate data, automate data harmonization, and facilitate interactive analysis at scale. By offering tools for data preparation, intelligent harmonization, and collaborative insights, ClearStory Data empowers business users to make informed decisions quickly and efficiently. As of April 2019, ClearStory Data operates as a subsidiary of Alteryx, Inc.

HEAVY.AI

Series A in 2016
HEAVY.AI is a developer of a big data analytics and visualization platform that enables businesses and government entities to uncover valuable opportunities and risks within extensive location and time-based data. By leveraging the capabilities of modern GPU and CPU hardware, HEAVY.AI's platform provides a structured query language-compliant database and an advanced visual analytics engine. This technology allows users to effectively analyze and visualize multi-billion record datasets through a web-based interface. The company's solutions are utilized across various sectors, including government, telecommunications, energy, utilities, and higher education, facilitating high-impact decision-making and enhancing the ability to derive insights from complex data.

Percolata

Venture Round in 2016
Percolata is a Palo Alto-based startup that provides an innovative hardware and software platform designed to help retailers optimize in-store customer traffic and staffing. By utilizing technologies such as video, audio, and mobile fingerprinting, the company employs artificial intelligence and predictive analytics to forecast foot traffic and sales on an hourly basis. This allows retailers to align their staffing levels with customer demand, enhancing operational efficiency. Percolata's solution can lead to significant improvements in sales performance, with reported increases of up to 30%, while also reducing costs associated with both understaffing and overstaffing.

ClearStory Data

Venture Round in 2016
ClearStory Data Inc. is a data analytics company based in Menlo Park, California, with an additional office in Chicago, Illinois. Founded in 2011, it provides business-oriented data analytics solutions that cater to a variety of industries, including consumer packaged goods, healthcare, manufacturing, and financial services. ClearStory Data's platform enables organizations to discover, analyze, and utilize data from various sources, such as relational databases, web applications, and third-party providers. The solution is designed to simplify access to disparate data, automate data harmonization, and facilitate interactive analysis at scale. By offering tools for data preparation, intelligent harmonization, and collaborative insights, ClearStory Data empowers business users to make informed decisions quickly and efficiently. As of April 2019, ClearStory Data operates as a subsidiary of Alteryx, Inc.

Oration

Series A in 2015
Oration is a healthcare technology company that focuses on simplifying the prescription purchasing process through its innovative management platform. The platform employs predictive analytics to enhance the user experience by factoring in cost and personal preferences, ultimately helping consumers save money that might otherwise be lost in the healthcare system. Over the past year, Oration has analyzed over one billion dollars in healthcare transactions, collaborating with major industry players to address complex challenges within the healthcare landscape. The company aims to create meaningful solutions that directly impact individuals in need, fostering an environment where innovation thrives without unnecessary bureaucracy.

PatientPing

Series A in 2015
PatientPing, Inc. is a health technology company that has developed a national care coordination network aimed at enhancing communication among healthcare providers. Founded in 2013 and headquartered in Boston, Massachusetts, the company offers real-time notifications and care guidelines to various healthcare professionals, including physicians, nurses, case managers, and care coordinators. This network spans hospitals, emergency departments, accountable care organizations, physician practices, skilled nursing facilities, home health agencies, and payers. PatientPing's platform includes a tool called Spotlights, which leverages real-time data to analyze utilization and performance trends in patient care. By improving information sharing among care teams, PatientPing facilitates higher quality, cost-effective care, ultimately aiming to enhance patient outcomes and experiences. The company also maintains a strategic partnership with MedAllies, Inc. and operates as a subsidiary of SVB Leerink Holdings LLC.

DFKI

Venture Round in 2015
The German Research Center for Artificial Intelligence (DFKI) GmbH was founded in 1988 as a Public-Private Partnership (PPP). It maintains offices in Kaiserslautern, Saarbrücken, Bremen and a project office in Berlin. DFKI is in the field of innovative software technology based on artificial intelligence techniques, the leading economic research center in Germany. In fifteen research areas and research groups, eight competence centers and six Living Labs product features, prototypes and patentable solutions in the field of information and communication technology will be developed starting from application-oriented basic research. Funding is provided through tendering of public funding authorities such as the European Union, the Federal Ministry of Education and Research (BMBF), the Federal Ministry of Economics and Technology (BMWi), the federal states and the German Research Foundation (DFG) as well as by development contracts from industry. The progress of publicly funded projects will be reviewed twice a year by an international expert panel (Scientific Advisory Board). As part of the five-yearly evaluation by the BMBF, DFKI in 2010 was again a very positive rating. In addition to the federal states of Rhineland-Palatinate, Saarland and Bremen numerous well-known German and foreign high-tech companies are represented in the DFKI Supervisory Board. The successful DFKI model of a non-profit public-private partnership is considered both nationally and internationally as a pioneering structure in the field of cutting-edge research. DFKI is involved in numerous committees for science and technology in Germany and enjoys high reputation far beyond Germany in the training of young scientists. Currently 457 highly qualified scientists and 371 student employees from more than 60 nations to 180 research projects. DFKI serves as a career springboard for young scientists in leadership positions in industry or in self-employment through spin-off companies. More than 60 employees were appointed over the years as professors on chairs at universities and colleges in Germany and abroad.

Cohesity

Series B in 2015
Cohesity, Inc. is a data management technology company that specializes in hyper-converged secondary storage solutions for large organizations. Founded in 2013 and based in Santa Clara, California, with an additional office in Raleigh, North Carolina, Cohesity aims to simplify the protection, management, and extraction of value from data. Its flagship product, the Cohesity DataPlatform, consolidates secondary data and workflows, eliminating storage silos and streamlining data management. The company also offers DataProtect, which integrates various data protection functions, including backup and disaster recovery, as well as the Cohesity Orion platform for comprehensive data protection and big data storage. Additionally, Cohesity provides tools for monitoring and managing data infrastructure through its SaaS-based solution, Cohesity Helios, and its mobile application. The company serves clients across the Americas, EMEA, and APAC, and maintains a strategic partnership with Pure Storage to enhance its offerings.

Metabiota

Series A in 2015
Metabiota, Inc. is a San Francisco-based company founded in 2008 that specializes in assessing and investigating infectious disease threats. The company employs pathogen discovery, disease detection, and threat characterization to provide data, analytics, and strategies aimed at reducing and preventing infectious disease outbreaks. Metabiota’s platform allows local authorities and organizations to prepare mitigation strategies and manage complex infectious disease risks effectively. By offering surveillance, recognition, and diagnosis of microbial threats, Metabiota plays a critical role in helping governments and corporations track and respond to global health challenges. Through its strategic global presence and partnerships, the company is dedicated to mitigating the impacts of epidemic threats.

Clarifai

Series A in 2015
Clarifai, Inc. is a prominent provider of advanced artificial intelligence solutions specializing in image recognition, natural language processing, and audio recognition. Established in 2013 and headquartered in New York, the company has developed a comprehensive platform that allows organizations to transform unstructured data—such as images, videos, and text—into structured formats with greater speed and accuracy than human capabilities. Clarifai's technology includes sophisticated systems for detecting near-duplicates and enabling visual searches, as well as a labeling tool that assists users in managing and training AI models. The company has gained recognition for its innovation in the field, notably securing top positions in the 2013 ImageNet Challenge. With a workforce spread across various countries, including the United States, Canada, Estonia, Argentina, and India, Clarifai continues to lead in the AI landscape by enhancing the way organizations utilize visual data.

Percolata

Seed Round in 2015
Percolata is a Palo Alto-based startup that provides an innovative hardware and software platform designed to help retailers optimize in-store customer traffic and staffing. By utilizing technologies such as video, audio, and mobile fingerprinting, the company employs artificial intelligence and predictive analytics to forecast foot traffic and sales on an hourly basis. This allows retailers to align their staffing levels with customer demand, enhancing operational efficiency. Percolata's solution can lead to significant improvements in sales performance, with reported increases of up to 30%, while also reducing costs associated with both understaffing and overstaffing.

Adelphic

Series B in 2014
Adelphic, Inc. is a company that specializes in developing a mobile and cross-channel programmatic advertising platform aimed at connecting brands with audiences. Founded in 2011 and based in Waltham, Massachusetts, Adelphic offers a self-service software solution that allows non-technical users to manage advertising campaigns effectively. Its platform is designed to facilitate meaningful engagements with consumers across various devices and formats, utilizing real-time bidding capabilities to ensure global reach. Key features of the platform include a campaign management portal, Audience Cube for data segmentation and insights, and predictive performance engine solutions. Adelphic primarily serves agencies, brands, and large media buyers, enabling them to overcome user identification limitations in digital advertising by providing rich, detailed profiles of consumers. As of early 2017, Adelphic operates as a subsidiary of Viant Technology Inc.

Framed Data

Seed Round in 2014
Framed Data is a technology company specializing in transforming business data into actionable insights. It harnesses machine learning to develop an analytic marketing platform that identifies high-value users, predicts user behavior, and monitors user retention. By training, optimizing, and storing production models in the cloud, Framed Data offers predictions through an API, thereby reducing the need for extensive infrastructure. Additionally, the company provides user-friendly dashboards and scenario analysis tools that help businesses understand the key factors influencing important metrics. Through its innovative approach, Framed Data empowers organizations to make informed decisions based on comprehensive data analysis.

HEAVY.AI

Seed Round in 2014
HEAVY.AI is a developer of a big data analytics and visualization platform that enables businesses and government entities to uncover valuable opportunities and risks within extensive location and time-based data. By leveraging the capabilities of modern GPU and CPU hardware, HEAVY.AI's platform provides a structured query language-compliant database and an advanced visual analytics engine. This technology allows users to effectively analyze and visualize multi-billion record datasets through a web-based interface. The company's solutions are utilized across various sectors, including government, telecommunications, energy, utilities, and higher education, facilitating high-impact decision-making and enhancing the ability to derive insights from complex data.

Tala

Seed Round in 2014
Tala is a global financial technology company focused on delivering accessible financial services to underserved populations in emerging markets, including Kenya, the Philippines, Mexico, and India. The company operates a mobile application that provides users with instant access to a range of financial services, such as credit, payments, savings, and transfers, effectively integrating digital and cash economies. Tala employs advanced data science and machine learning techniques to evaluate creditworthiness in real-time, allowing individuals without formal credit histories to receive personalized credit lines. This innovative approach helps bridge the financial inclusion gap for those in need of essential financial resources.

Stackdriver

Acquisition in 2014
Stackdriver is a provider of a management platform designed for cloud-powered applications, focusing on monitoring and improving the performance of systems and infrastructure. Founded in 2012 and acquired by Google in 2014, Stackdriver offers an intuitive software-as-a-service (SaaS) solution that enables DevOps teams to spend more time on development rather than operations. Its Intelligent Monitoring features include Rapid Stack Discovery, which quickly maps relationships between system resources, and Stack Scanner, an analytics engine that detects performance issues and predicts capacity constraints. Additionally, Elastic Monitoring allows for the oversight of dynamic resources without the need for manual adjustments, while AWS Insights correlates AWS events with performance data to identify optimization opportunities. Stackdriver's services are utilized by numerous innovative companies, making it a standard choice for system and infrastructure monitoring.

ClearStory Data

Series B in 2014
ClearStory Data Inc. is a data analytics company based in Menlo Park, California, with an additional office in Chicago, Illinois. Founded in 2011, it provides business-oriented data analytics solutions that cater to a variety of industries, including consumer packaged goods, healthcare, manufacturing, and financial services. ClearStory Data's platform enables organizations to discover, analyze, and utilize data from various sources, such as relational databases, web applications, and third-party providers. The solution is designed to simplify access to disparate data, automate data harmonization, and facilitate interactive analysis at scale. By offering tools for data preparation, intelligent harmonization, and collaborative insights, ClearStory Data empowers business users to make informed decisions quickly and efficiently. As of April 2019, ClearStory Data operates as a subsidiary of Alteryx, Inc.

CircleUp

Series B in 2014
CircleUp is a San Francisco-based company established in 2012, operating an online platform that connects early-stage consumer and retail brands with accredited investors. The platform facilitates capital raising and provides resources to these companies, enabling them to grow and scale. CircleUp's proprietary machine learning platform, Helio, evaluates and predicts the potential success of over 1.3 million consumer businesses, aiding in the discovery and selection of promising investment opportunities.

Metabiota

Seed Round in 2014
Metabiota, Inc. is a San Francisco-based company founded in 2008 that specializes in assessing and investigating infectious disease threats. The company employs pathogen discovery, disease detection, and threat characterization to provide data, analytics, and strategies aimed at reducing and preventing infectious disease outbreaks. Metabiota’s platform allows local authorities and organizations to prepare mitigation strategies and manage complex infectious disease risks effectively. By offering surveillance, recognition, and diagnosis of microbial threats, Metabiota plays a critical role in helping governments and corporations track and respond to global health challenges. Through its strategic global presence and partnerships, the company is dedicated to mitigating the impacts of epidemic threats.

DataFox

Seed Round in 2014
DataFox is a company intelligence platform based in San Francisco, specializing in providing comprehensive insights into private companies for sales, marketing, and investment teams. The platform combines artificial intelligence and data science to create proprietary datasets, offering features such as Company Data, Growth Signals, and Account Scoring. DataFox employs a team of over 100 analysts who verify AI-generated insights on millions of businesses, ensuring the accuracy and reliability of the information. The platform is designed to help users prioritize target companies and identify new opportunities, making it a valuable resource for both high-growth startups and Fortune 500 companies. Notable clients include UPS, Accel Partners, Bain & Company, Twilio, Zendesk, and Outreach.

Industrial Pereception

Acquisition in 2013
Industrial Pereception is home to some of the world’s foremost authorities and pioneers in machine vision and artificial intelligence.

DataFox

Seed Round in 2013
DataFox is a company intelligence platform based in San Francisco, specializing in providing comprehensive insights into private companies for sales, marketing, and investment teams. The platform combines artificial intelligence and data science to create proprietary datasets, offering features such as Company Data, Growth Signals, and Account Scoring. DataFox employs a team of over 100 analysts who verify AI-generated insights on millions of businesses, ensuring the accuracy and reliability of the information. The platform is designed to help users prioritize target companies and identify new opportunities, making it a valuable resource for both high-growth startups and Fortune 500 companies. Notable clients include UPS, Accel Partners, Bain & Company, Twilio, Zendesk, and Outreach.

Percolata

Convertible Note in 2013
Percolata is a Palo Alto-based startup that provides an innovative hardware and software platform designed to help retailers optimize in-store customer traffic and staffing. By utilizing technologies such as video, audio, and mobile fingerprinting, the company employs artificial intelligence and predictive analytics to forecast foot traffic and sales on an hourly basis. This allows retailers to align their staffing levels with customer demand, enhancing operational efficiency. Percolata's solution can lead to significant improvements in sales performance, with reported increases of up to 30%, while also reducing costs associated with both understaffing and overstaffing.

CircleUp

Series A in 2013
CircleUp is a San Francisco-based company established in 2012, operating an online platform that connects early-stage consumer and retail brands with accredited investors. The platform facilitates capital raising and provides resources to these companies, enabling them to grow and scale. CircleUp's proprietary machine learning platform, Helio, evaluates and predicts the potential success of over 1.3 million consumer businesses, aiding in the discovery and selection of promising investment opportunities.

Optimizely

Series A in 2013
Optimizely, Inc. is a company that operates a website optimization platform designed for A/B testing, multivariate testing, and website personalization, catering to both technical and non-technical users. Founded in 2009 and headquartered in San Francisco, California, it also has offices in Amsterdam, Sydney, and Austin. The platform allows organizations to conduct experiments that facilitate data-driven decision-making and is available in multiple languages, making it accessible to a global audience. Optimizely's offerings include web content management, digital experience software, and integrated capabilities for content, commerce, multi-channel marketing, and predictive analytics. The company serves a diverse clientele, including agencies, developers, e-commerce businesses, enterprises, publishers, and small businesses primarily in the United States, Germany, the United Kingdom, and Spain. Optimizely, formerly known as Spreadly, operates as a subsidiary of EPiServer AB.

Osito

Seed Round in 2013
Osito (formerly Sherpa) is a predictive intelligence iOS app and platform that gets you the information you need so you can stay one step ahead every day. By combining the power of location data with updates from your calendar, email and daily routine, Osito manages the details of everything from work travel to your weekly meetings and commute. Unlike other applications, services or even personal assistants out there, Osito is proactive, not reactive – and location, not calendar based. It learns what you need to know based on the information you provide, including your location as well as your day-to-day routine – making every day just a little easier. Osito was part of **[AngelPad](http://angelpad.org) #4** in 2012.

ClearStory Data

Series A in 2012
ClearStory Data Inc. is a data analytics company based in Menlo Park, California, with an additional office in Chicago, Illinois. Founded in 2011, it provides business-oriented data analytics solutions that cater to a variety of industries, including consumer packaged goods, healthcare, manufacturing, and financial services. ClearStory Data's platform enables organizations to discover, analyze, and utilize data from various sources, such as relational databases, web applications, and third-party providers. The solution is designed to simplify access to disparate data, automate data harmonization, and facilitate interactive analysis at scale. By offering tools for data preparation, intelligent harmonization, and collaborative insights, ClearStory Data empowers business users to make informed decisions quickly and efficiently. As of April 2019, ClearStory Data operates as a subsidiary of Alteryx, Inc.

Adelphic

Series A in 2012
Adelphic, Inc. is a company that specializes in developing a mobile and cross-channel programmatic advertising platform aimed at connecting brands with audiences. Founded in 2011 and based in Waltham, Massachusetts, Adelphic offers a self-service software solution that allows non-technical users to manage advertising campaigns effectively. Its platform is designed to facilitate meaningful engagements with consumers across various devices and formats, utilizing real-time bidding capabilities to ensure global reach. Key features of the platform include a campaign management portal, Audience Cube for data segmentation and insights, and predictive performance engine solutions. Adelphic primarily serves agencies, brands, and large media buyers, enabling them to overcome user identification limitations in digital advertising by providing rich, detailed profiles of consumers. As of early 2017, Adelphic operates as a subsidiary of Viant Technology Inc.

Predilytics

Series A in 2012
Predilytics, Inc. is a healthcare information technology company that specializes in providing analytic solutions for health plans, providers, and other risk-bearing entities. Founded in 2011 and headquartered in Burlington, Massachusetts, Predilytics harnesses machine-learning tools to analyze both structured and unstructured data, integrating external data sources to generate actionable insights. The company offers a range of solutions aimed at improving healthcare outcomes, including Consumer Acquisition and Retention solutions, which help organizations understand consumer behavior for better product design; Care Directions solutions, targeting high-risk members for effective care management; Risk Adjustment solutions, enhancing reimbursement accuracy and quality of care; and Quality Insight solutions, which identify performance gaps to drive improvements. By focusing on predictive analytics, Predilytics enables healthcare organizations to optimize care delivery, control costs, and improve population health.

ClearStory Data

Venture Round in 2012
ClearStory Data Inc. is a data analytics company based in Menlo Park, California, with an additional office in Chicago, Illinois. Founded in 2011, it provides business-oriented data analytics solutions that cater to a variety of industries, including consumer packaged goods, healthcare, manufacturing, and financial services. ClearStory Data's platform enables organizations to discover, analyze, and utilize data from various sources, such as relational databases, web applications, and third-party providers. The solution is designed to simplify access to disparate data, automate data harmonization, and facilitate interactive analysis at scale. By offering tools for data preparation, intelligent harmonization, and collaborative insights, ClearStory Data empowers business users to make informed decisions quickly and efficiently. As of April 2019, ClearStory Data operates as a subsidiary of Alteryx, Inc.

Optimizely

Seed Round in 2012
Optimizely, Inc. is a company that operates a website optimization platform designed for A/B testing, multivariate testing, and website personalization, catering to both technical and non-technical users. Founded in 2009 and headquartered in San Francisco, California, it also has offices in Amsterdam, Sydney, and Austin. The platform allows organizations to conduct experiments that facilitate data-driven decision-making and is available in multiple languages, making it accessible to a global audience. Optimizely's offerings include web content management, digital experience software, and integrated capabilities for content, commerce, multi-channel marketing, and predictive analytics. The company serves a diverse clientele, including agencies, developers, e-commerce businesses, enterprises, publishers, and small businesses primarily in the United States, Germany, the United Kingdom, and Spain. Optimizely, formerly known as Spreadly, operates as a subsidiary of EPiServer AB.

tenXer

Series A in 2011
tenXer is a company focused on enhancing personal productivity through a data-driven platform designed for individual employees. Founded by Jeff Ma, who is also known for his involvement in the story behind the film 21, tenXer aims to address the needs of everyday workers rather than upper management. The platform collects data from various tools and services that users already engage with, presenting this information in an engaging format. By combining productivity analytics with social and game-like motivational systems, tenXer helps users gain insights into their work habits, thereby fostering intrinsic motivation and improving overall performance. This innovative approach positions tenXer as a significant player in the human capital management industry, emphasizing the importance of individual contributions to organizational productivity.

PittPatt

Acquisition in 2011
Pittsburgh Pattern Recognition (PittPatt) develops reliable face recognition software for images and video.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.